ANDA 84292, held by Sandoz. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 84292 (Butabarbital Sodium), held by Sandoz, was not approved, with 11 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Butabarbital Sodium15MG ยท tablet;oral | Butabarbital Sodium | Discontinued |
| Aug 16, 1985 | Supplement 65Manufacturing | Approved | None posted |
| Jun 5, 1984 | Supplement 62Manufacturing | Approved | None posted |
| Jun 5, 1984 | Supplement 63Manufacturing | Approved | None posted |
| Jul 21, 1983 | Supplement 60Manufacturing | Approved | None posted |
| Jul 21, 1983 | Supplement 61Manufacturing | Approved | None posted |
| Jun 3, 1983 | Supplement 57Manufacturing | Approved | None posted |
| May 16, 1983 | Supplement 59Manufacturing | Approved | None posted |
| Mar 30, 1983 | Supplement 55Manufacturing | Approved | None posted |
| Feb 9, 1982 | Supplement 50Manufacturing | Approved | None posted |
| Feb 9, 1982 | Supplement 51Manufacturing | Approved | None posted |
| Feb 9, 1982 | Supplement 52Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters